Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...

Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...

Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...

Synthetic biologists from Yale were able to re-write the genetic code of an organism — a novel genomically recoded organism ...

This study is the first to demonstrate that certain tRNA introns influence gene expression. Scientists have discovered that ...

MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...

Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...

Japanese researchers enhance mRNA cancer drugs protein synthesis efficiency by 200 times Japanese scientists develop ...

A new MIT study in Cell Reports shows that enhancing activity of a specific component of ‘NMDA’ receptors normalizes protein ...

Synthetic biologists from Yale were recode the genetic code of an organism, a novel genomically recoded organism (GRO) with ...

The main difference between collagen and whey protein is their amino acid profile and health benefits. Collagen's amino acids ...

MIT researchers suggests a potential molecular strategy for treating fragile X syndrome by enhancing NMDA subunit function.